Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care

Journal of Palliative Medicine

Volumn 13, Issue 7, 2010, Pages 903-908

  Irwin, Scott A ^a   Iglewicz, Alana ^b  

^a Institute for Palliative Medicine at San Diego Hospice   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CIPROFLOXACIN; DEXAMETHASONE; DIAZEPAM; DOCUSATE SODIUM; DULOXETINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FUROSEMIDE; GABAPENTIN; KETAMINE; LACTULOSE; LIDOCAINE; METHADONE; MORPHINE; MORPHINE SULFATE; NAPROXEN; OXYCODONE PLUS PARACETAMOL; PREDNISONE; RISEDRONIC ACID; SALBUTAMOL SULFATE; TIOTROPIUM BROMIDE; TIZANIDINE; TRAZODONE;

ADULT; ADVERSE DRUG REACTION; AGED; ANHEDONIA; ANXIETY DISORDER; ARTICLE; BONE METASTASIS; BRIEF PSYCHIATRIC RATING SCALE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; DECREASED APPETITE; DELIRIUM; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EVENING DOSAGE; FEMALE; GUILT; HAMILTON ANXIETY SCALE; HOPELESSNESS; HOSPICE CARE; HUMAN; HYPERSOMNIA; LIVER METASTASIS; LUNG METASTASIS; MALE; MINI MENTAL STATE EXAMINATION; OXYGEN THERAPY; PANIC; PROSTATE CANCER; RESPIRATORY FAILURE; SENNA; SUICIDAL IDEATION; TREATMENT RESPONSE; URINARY TRACT INFECTION; WEIGHT REDUCTION; YOUNG MANIA RATING SCALE;

ADMINISTRATION, ORAL; AGED; ANALGESICS; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPICE CARE; HUMANS; KETAMINE; MALE; MIDDLE AGED;

EID: 77954950428     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.9808     Document Type: Article

References (33)

1. Wilson KG, Chochinov HM, de Faye BJ, Breitbart W: Diagnosis and management of depression in palliative care. In: Chochinov HM, Breitbart W, eds. Handbook of Psychiatry in Palliative Medicine. New York: Oxford University Press; 2000:25-50.
2. National Institutes of Health: National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst Monographs 2004;2004:9-16.
3. Wilson KG, Chochinov HM, Skirko MG, Allard P, Chary S, Gagnon PR, Macmillan K, De Luca M, O'Shea F, Kuhl D, Fainsinger RL, Clinch JJ: Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage 2007;33: 118-129.
4. Goldberg RJ, Mor V: A survey of psychotropic use in terminal cancer patients. Psychosomatics 1985;26:745-748, 751.
5. McDaniel JS, Brown FW, Cole SA: Assessment of depression and grief reactions in the medically ill. In: Stoudemire A, Fogel BS, Greenberg DB, eds. Psychiatric Care of the Medical Patient. New York: Oxford University Press; 2000:149-164.
6. King DA, Heisel MJ, Lyness JM: Assessment and psychological treatment of depression in older adults with terminal or life threatening illness. Clin Psychol Sci Pract 2005:339-353.
7. Spiegel D, Bloom JR: Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 1983;45: 333-339.
8. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge; New York: Cambridge University Press; 2008:1117.
9. Irwin SA, Ferris FD: The opportunity for psychiatry in palliative care. Can J Psychiatry 2008;53:713-724.
10. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163: 28-40.
11. Thase ME, Friedman ES, Biggs MM, Wisniewski SR, Trivedi MH, Luther JF, Fava M, Nierenberg AA, McGrath PJ, Warden D, Niederehe G, Hollon SD, Rush AJ: Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry 2007;164:739-752.
12. NHPCO. NHPCO's Facts and Figures-2005 Findings. In: Organization NHaPC, ed. http://www.nhpco.org/i4a/ pages/index.ctm?pageid=5994. Vol.2007: National Hospice and Palliative Care Organization, 2006.
13. Sood A, Barton DL, Loprinzi CL: Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 2006;23:35-40.
14. Rozans M, Dreisbach A, Lertora JJL, Kahn MJ: Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 2002;20:335-339.
15. Krystal JH: Ketamine and the potential role for rapid-acting antidepressant medications. Swiss Med Wkly 2007;137:215-216.
16. Kudoh A, Takahira Y, Katagai H, Takazawa T: Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 2002;95:114-118, table of contents.
17. Zarate CA, Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK: A randomized trial of an N-methyl-D-aspartate antagonist in treatment- resistant major depression. Arch Gen Psychiatry 2006;63: 856-864.
18. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-354.
19. Correll GE, Futter GE: Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions. Pain Med 2006;7:92-95.
20. Liebrenz M, Borgeat A, Leisinger R, Stohler R: Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly 2007;137:234-236.
21. Liebrenz M, Stohler R, Borgeat A: Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. World J Biol Psychiatry 2007:1-4.
22. Stefanczyk-Sapieha L, Oneschuk D, Demas M: Intravenous ketamine "burst" for refractory depression in a patient with advanced cancer. J Palliat Med 2008;11:1268-1271.
23. Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S: Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005;30:485-491.
24. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, Firestone L, Lavin PT, Mermelstein F: Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 2004;108:17-27.
25. Kannan TR, Saxena A, Bhatnagar S, Barry A: Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage 2002;23:60-65.
26. Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL: Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999;90:1528-1533.
27. Mercadante S, Arcuri E, Tirelli W, Casuccio A: Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 2000;20: 246-252.
28. Subramaniam K, Subramaniam B, Steinbrook RA: Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004;99:482-495, table of contents.
29. Lossignol DA, Obiols-Portis M, Body JJ: Successful use of ketamine for intractable cancer pain. Support Care Cancer 2005;13:188-193.
30. Fitzgibbon EJ, Hall P, Schroder C, Seely J, Viola R: Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from paren- teral to oral ketamine. J Pain Symptom Manage 2002;23: 165-170.
31. Fine PG: Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage 1999;17:296-300.
32. Clark JL, Kalan GE: Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage 1995;10:310-314.
33. Evers AS, Crowder CM, Balser JR: Chapter 13: General Anesthetics in: Brunton LL, Lazo JS, Parker KL: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e. http://www.accessmedicine.com content.aspx?aID=937527